NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE135881 Query DataSets for GSE135881
Status Public on Aug 16, 2019
Title Glucagon-receptor signaling regulates energy metabolism via hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Glucagon, an essential regulator of glucose and lipid metabolism, also promotes weight loss, in part through potentiation of fibroblast-growth factor 21 (FGF21) secretion. However, FGF21 is only a partial mediator of metabolic actions ensuing from GcgR-activation, prompting us to search for additional pathways. Intriguingly, chronic GcgR agonism increases plasma bile acid levels. We hypothesized that GcgR agonism regulates energy metabolism, at least in part, through farnesoid X receptor (FXR). To test this hypothesis, we studied whole body and liver-specific FXR knockout (FXR∆liver) mice. Chronic GcgR agonist (IUB288) administration in diet-induced obese (DIO) Gcgr, Fgf21 and Fxr whole body or liver-specific knockout (∆liver) mice failed to reduce body weight (BW) when compared to wildtype (WT) mice. IUB288 increased energy expenditure and respiration in DIO WT mice, but not FXR∆liver mice. GcgR agonism increased [14C]-palmitate oxidation in hepatocytes isolated from WT mice in a dose-dependent manner, an effect blunted in hepatocytes from FXR∆liver mice. Our data clearly demonstrate that control of whole body energy expenditure by GcgR agonism requires intact FXR signaling in the liver. This heretofore-unappreciated aspect of glucagon biology has implications for the use of GcgR agonism in the therapy of metabolic disorders.
 
Overall design RNA sequencing analysis of mice given IUB288 or vehicle treatment. Fxr-floxed mice were were used relative to wild-type controls. All mice were vmaintained on a C57Bl/6J background.
Web link https://diabetes.diabetesjournals.org/content/67/9/1773.long
 
Contributor(s) Pepin ME, Kim T, Nason S, Holleman C, Wilson L, Berryhill T, Wende AR, Steele C, Young M, Barnes S, Drucker D, Finan B, DiMarchi R, Perez-Tilve D, Tschoep M, Habegger KM
Citation(s) 29925501
Submission date Aug 15, 2019
Last update date Nov 15, 2019
Contact name Mark Emile Pepin
E-mail(s) pepinme@gmail.com
Organization name University of Alabama at Birmingham
Department Biomedical Engineering
Lab Adam Wende Laboratory
Street address 1825 University Blvd
City Birmingham
State/province AL
ZIP/Postal code 35294-2182
Country USA
 
Platforms (1)
GPL17021 Illumina HiSeq 2500 (Mus musculus)
Samples (8)
GSM4037070 Liver, 156WT, IUB288
GSM4037071 Liver, 141WT, Vehicle
GSM4037072 Liver, 135KO, Vehicle
Relations
BioProject PRJNA560395
SRA SRP218456

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE135881_IUB288_KO_vs_IUB288_WT_gene_differential_expression.xlsx 4.7 Mb (ftp)(http) XLSX
GSE135881_IUB288_KO_vs_Veh_KO_gene_differential_expression.xlsx 5.2 Mb (ftp)(http) XLSX
GSE135881_IUB288_WT_vs_Veh_WT_gene_differential_expression.xlsx 5.3 Mb (ftp)(http) XLSX
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap